Use of a Scalable Replicon-Particle Vaccine to Protect Against Lethal Lassa Virus Infection in the Guinea Pig Model-Reference-Cited by-同舟云学术

Use of a Scalable Replicon-Particle Vaccine to Protect Against Lethal Lassa Virus Infection in the Guinea Pig Model

Published:2018-03-06 Issue:12 Volume:217 Page:1957-1966
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Kainulainen Markus H¹,Spengler Jessica R¹,Welch Stephen R¹,Coleman-McCray JoAnn D¹,Harmon Jessica R¹,Klena John D¹,Nichol Stuart T¹,Albariño César G¹,Spiropoulou Christina F¹

Affiliation:

1. Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/217/12/1957/25090688/jiy123.pdf

Reference50 articles.

1. Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings;Frame;Am J Trop Med Hyg,1970

2. Lassa fever, a new virus disease of man from West Africa. II. Report of a laboratory-acquired infection treated with plasma from a person recently recovered from the disease;Leifer;Am J Trop Med Hyg,1970

3. Lassa fever, a new virus disease of man from West Africa. IV. Electron microscopy of Vero cell cultures infected with Lassa virus;Speir;Am J Trop Med Hyg,1970

4. Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone;Monath;Science,1974

5. Lassa fever in the Eastern province of Sierra Leone, 1970–1972. I. Epidemiologic studies;Fraser;Am J Trop Med Hyg,1974

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel BSL-2 Lassa virus reverse genetics system modelling the complete viral life cycle;Emerging Microbes & Infections;2024-06-10

2. A Lassa virus mRNA vaccine confers protection but does not require neutralizing antibody in a guinea pig model of infection;Nature Communications;2023-09-12

3. Single-dose mucosal replicon-particle vaccine protects against lethal Nipah virus infection up to 3 days after vaccination;Science Advances;2023-08-04

4. Immunogenesis in Lassa fever and prospects for vaccine development;Journal of microbiology, epidemiology and immunobiology;2023-05-22

5. Lassa Virus Infection: a Summary for Clinicians;International Journal of Infectious Diseases;2022-06